思略特2024利用人工智能重塑制药行业报告英文版20页

Re-inventing Pharma with Artificial IntelligenceThree steps for pharmaceutical companies to seize the $250bn AI value potential in the future of healthContactsAustriaMatthias SchlemmerPartner, Strategy& Austria+43-664-5152-939matthias.schlemmer@pwc.comGermanyDr. Christian KasparPartner, Strategy& Germany+49-170-9362-692christian.kaspar@pwc.comDr. Jens NeumannPartner, Strategy& Germany+49-172-2337/689jens.neumann@pwc.comDr. Thomas SolbachPartner, Strategy& Germany+49-170-2238-477thomas.solbach@pwc.comSwitzerlandMatthias LeyboldPartner, PwC Switzerland+41-58-792-1396matthias.leybold@pwc.chUnited KingdomColin LightPartner, Strategy& UK+44-7782-329-322colin.m.light@pwc.comThalita MarinhoPartner, Strategy& UK+44-7900-163-439thalita.marinho@pwc.comUnited StatesRonald ChopoorianPartner, PwC United States+1-973-449-6042ronald.chopoorian@pwc.comPhilip SclafaniPartner, PwC United States+1-631-767-2540philip.sclafani@pwc.comAbout the authorsDr. Christian Kaspar is a partner with Strategy& Ger